10.18
1.90%
+0.19
After Hours:
10.19
0.010
+0.10%
Enhabit Inc stock is currently priced at $10.18, with a 24-hour trading volume of 274.77K.
It has seen a +1.90% increased in the last 24 hours and a -7.37% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $10.07 pivot point. If it approaches the $10.24 resistance level, significant changes may occur.
Previous Close:
$9.99
Open:
$10.19
24h Volume:
274.77K
Market Cap:
$510.08M
Revenue:
$1.05B
Net Income/Loss:
$-80.50M
P/E Ratio:
-9.0893
EPS:
-1.12
Net Cash Flow:
$44.90M
1W Performance:
+1.50%
1M Performance:
-7.37%
6M Performance:
+17.42%
1Y Performance:
-17.10%
Enhabit Inc Stock (EHAB) Company Profile
Name
Enhabit Inc
Sector
Industry
Phone
214-239-6500
Address
6688 N. Central Expressway, Suite 1300, Dallas
Enhabit Inc Stock (EHAB) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-20-23 | Initiated | SVB Securities | Underperform |
Mar-16-23 | Initiated | Goldman | Neutral |
Dec-13-22 | Initiated | CJS Securities | Market Perform |
Dec-08-22 | Initiated | UBS | Sell |
Dec-06-22 | Initiated | Stifel | Buy |
Oct-14-22 | Initiated | Oppenheimer | Perform |
Aug-30-22 | Initiated | Jefferies | Buy |
Aug-25-22 | Initiated | Credit Suisse | Neutral |
Aug-18-22 | Initiated | Citigroup | Neutral |
View All
Enhabit Inc Stock (EHAB) Latest News
Enhabit Inc Stock (EHAB) Financials Data
Enhabit Inc (EHAB) Revenue 2024
EHAB reported a revenue (TTM) of $1.05 billion for the quarter ending December 31, 2023, a -2.32% decline year-over-year.
Enhabit Inc (EHAB) Net Income 2024
EHAB net income (TTM) was -$80.50 million for the quarter ending December 31, 2023, a -99.26% decrease year-over-year.
Enhabit Inc (EHAB) Cash Flow 2024
EHAB recorded a free cash flow (TTM) of $44.90 million for the quarter ending December 31, 2023, a -38.49% decrease year-over-year.
Enhabit Inc (EHAB) Earnings per Share 2024
EHAB earnings per share (TTM) was -$1.62 for the quarter ending December 31, 2023, a -229.28% decline year-over-year.
About Enhabit Inc
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
Cap:
|
Volume (24h):